gvtcx

Provision of integrated Medical Information Services - Programme CORTISONE

key details

Statusactive
Category (CPV) 48180000
RegionSouth West
Deadline1 Jun 2017
Contract start25 Jul 2017
Contract end23 Jul 2021
Procedureselective
SME suitableYes
OCIDocds-b5fd17-4faf1ac7-d140-4f5d-9f35-0f0685ad0765

description

This procurement is to supply off-the-shelf software products and vendor support to meet the requirements of themes 1 and 2.

This procurement is split into two parts.

Part 1 is a lot based competitive procurement that will award up to 19 individual contracts for Lot Solutions. The Contracts awarded at the end of Part 1 will support the Authority in conducting Part 2 which is referred to as the Solution Evolution and Evaluation (SE&E) Phase. The duration of the SE&E phase will have a duration of 13 months.

The purpose of the SE&E Phase is to determine the combination of contracts (up to 9) that may see their options exercised following approval of the CORTISONE Theme 1 and 2 Investment Approval Point Business Case. If approved, this option will cover the Live Phase of the programme which will have a duration of 36 months.

Additional information: To view this notice, register as a supplier here:

http://www.contracts.mod.uk/delta/signup.html?userType=supplier

and search for the notice with reference 'UK-Corsham: Medical software package.'.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
18 Feb 2017 Tender (tender) · a529a11d-0f86-47e9-a083-1827a87b9bff-131104
25 Sept 2017 Tender (tender) · a8e91919-f3e7-4e9e-a573-0917f0579c04-172280

more from Ministry of Defence, Information Systems and Services, ISS Development Pillar

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.